PBYI Return on Tangible Equity | PUMA BIOTECHNOLOGY, INC.

PUMA BIOTECHNOLOGY, INC. (PBYI) Return on Tangible Equity

2026-06-30: Return Tang Equity 27.50%.
2026-03-31: Return Tang Equity 28.02%.
2025-12-31: Return Tang Equity 34.98%.
2025-09-30: Return Tang Equity 57.65%.

Complete source-backed return tang equity history.

Available history: 2011-06-30 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	27.50%
2026-03-31	28.02%
2025-12-31	34.98%
2025-09-30	57.65%
2025-06-30	90.42%
2025-03-31	82.80%
2024-12-31	73.86%
2024-09-30	227.47%
2024-06-30	-70.54%
2024-03-31	-155.48%
2023-12-31	-290.63%
2023-09-30	-11.66%
2023-06-30	6.07%
2023-03-31	-10.74%
2022-12-31	-0.00%
2022-09-30	-22.36%
2022-06-30	74.33%
2022-03-31	83.01%
2021-12-31	42.33%
2021-09-30	56.72%
2021-06-30	78.43%
2021-03-31	45.90%
2020-12-31	74.91%
2020-09-30	137.36%
2020-06-30	244.00%
2020-03-31	265.22%
2019-12-31	328.70%
2019-09-30	349.24%
2019-06-30	408.21%
2019-03-31	10599.57%
2018-12-31	1124.29%
2018-09-30	6017.98%
2018-06-30	2087.69%
2018-03-31	-2674.52%
2017-12-31	-5901.66%
2017-09-30	-379.62%
2017-06-30	-240.73%
2017-03-31	-166.02%
2016-12-31	-131.54%
2016-09-30	-290.81%
2016-06-30	-204.37%
2016-03-31	-156.30%
2015-12-31	-116.15%
2015-09-30	-91.92%
2015-06-30	-72.96%
2015-03-31	-57.38%
2014-12-31	-121.29%
2014-09-30	-77.98%
2014-06-30	-53.20%
2014-03-31	-31.53%
2013-12-31	-65.08%
2013-09-30	-63.98%
2013-06-30	-67.46%
2013-03-31	-62.82%
2012-12-31	-57.68%
2012-09-30	-691.88%
2012-06-30	-131.16%
2012-03-31	-51.78%
2011-12-31	-18.82%
2011-09-30	121.31%
2011-06-30	3381.47%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	34.98%
2024-12-31	73.86%
2023-12-31	-290.63%
2022-12-31	-0.00%
2021-12-31	42.48%
2020-12-31	74.91%
2019-12-31	328.70%
2018-12-31	1124.28%
2017-12-31	-5901.66%
2016-12-31	-131.54%
2015-12-31	-116.15%
2014-12-31	-121.29%
2013-12-31	-65.08%
2012-12-31	-57.68%
2011-12-31	-18.82%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ARVINAS, INC. (ARVN)	United States	$0.510B	58.38
CAPRICOR THERAPEUTICS, INC. (CAPR)	United States	$0.499B	-10.81
Evolus, Inc. (EOLS)	United States	$0.519B	-13.32
Ovid Therapeutics Inc. (OVID)	United States	$0.487B	-14.41
CRESCENT BIOPHARMA, INC. (CBIO)	United States	$0.529B	-5.20
ASSEMBLY BIOSCIENCES, INC. (ASMB)	United States	$0.481B	-13,053.96
Indaptus Therapeutics, Inc. (INDP)	United States	$0.537B
MapLight Therapeutics, Inc. (MPLT)	United States	$0.459B	-7.10
Quoin Pharmaceuticals Ltd. (QNRX)		$0.443B	-17.85
Phathom Pharmaceuticals, Inc. (PHAT)	United States	$0.572B	-8.76